MVision AI

About:

MVision AI is a company that develops a SaaS based AI-powered solution for radiotherapy treatment planning to treat cancer

Website: http://www.mvision.ai

Twitter/X: mvisionai

Top Investors: J12, Icebreaker.vc, Voima Ventures, Asko Schrey, Nuard Ventures

Description:

MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatment outcome and saves money. The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare.

Total Funding Amount:

$8.23M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Helsinki, Southern Finland, Finland

Founded Date:

2017-10-10

Contact Email:

info(AT)mvision.ai

Founders:

Jarkko Niemelä, Mahmudul Hasan, Saad Ullah Akram

Number of Employees:

11-50

Last Funding Date:

2023-03-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai